In this piece we will look at the 5 Best Undervalued Stocks to Buy Under $100. Please visit 10 Best Undervalued Stocks to Buy Under $100 if you’d like to see an extended list and how we came up with the list of Best Undervalued Stocks to Buy Under $100.
5. United Parcel Service, Inc. (NYSE:UPS)
Price: $98.07
Fwd P/E Ratio: 13.54
Number of Hedge Fund Holders: 67
United Parcel Service, Inc. (NYSE:UPS) is one of the Best Undervalued Stocks to Buy Under $100. The stock currently trades at a forward price to earnings ratio of 13.54, which is significantly lower than the sector average of 20.46. On April 29, UBS lowered the firm’s price target on United Parcel Service, Inc. (NYSE:UPS) from $125 to $123, while keeping a Buy rating on the shares.
The rating follows the company’s fiscal Q1 2026 earnings release reported on April 28. During the quarter, the company posted $21.28 billion in revenue, reflecting 1.6% year-over-year decline but ahead of expectations by $228.23 million. The GAAP EPS of $1.20 also topped expectations by $0.02. Management noted that the revenue decline was due to an expected decline in volume. On the bright side, the revenue per piece grew 6.5% during the same time.
For the full year, the company reiterated its guidance of revenue around $89.7 billion and a non-GAAP adjusted operating margin of approximately 9.6%. Analyst at UBS noted that while the first quarter results presented upside for the company, execution remains a key lever going forward.
United Parcel Service, Inc. (NYSE:UPS) provides integrated logistics solutions for customers in more than 200 countries and territories. Its U.S. Domestic Package segment offers a range of United States domestic air and ground package transportation services.
4. Occidental Petroleum Corporation (NYSE:OXY)
Price: $59.34
Fwd P/E Ratio: 9.92
Number of Hedge Fund Holders: 67
Occidental Petroleum Corporation (NYSE:OXY) is one of our Best Undervalued Stocks to Buy Under $100. The company currently trades at a forward price to earnings ratio of 9.92, below the sector average of 12.58. Occidental Petroleum Corporation (NYSE:OXY) recently posted FQ1 2026 earnings on May 5.
During the quarter, the company posted $5.11 billion in revenue, down 25.34% year-over-year and below expectations by $556.23 million. The GAAP EPS of $3.13 also topped the consensus by $2.53. Management noted delivering 1.43 million BOE per day, ahead of the high end of the company’s guidance. This production came despite the lower international output from Middle East disruptions.
Following the release on May 7, UBS lowered the firm’s price target on Occidental Petroleum Corporation (NYSE:OXY) from $67 to $65, while maintaining a Neutral rating on the shares. The firm noted that the company’s long-term philosophy is leading to free cash flow growth. During the quarter, the company generated approximately $1.7 billion before working capital, representing an increase of about 52% from continuing operations. This was driven by cost and operational efficiency, despite oil prices similar to those in 2025.
Occidental Petroleum Corporation (NYSE:OXY) is an international energy company with assets primarily located in the United States, the Middle East, and North Africa. The company produces oil and gas in the United States, including operations in the Permian Basin, DJ Basin, and the offshore Gulf of Mexico.
3. Wells Fargo & Company (NYSE:WFC)
Price: $79.89
Fwd P/E Ratio: 11.31
Number of Hedge Fund Holders: 72
Wells Fargo & Company (NYSE:WFC) is one of the Best Undervalued Stocks to Buy Under $100. Recently, on May 7, Phillip Securities upgraded Wells Fargo & Company (NYSE:WFC) to Buy from Accumulate with a $98 price target. Earlier on April 30, J.P. Morgan lowered the firm’s price target on the stock from $91 to $86.5 and maintained a Neutral rating on the shares.
The ratings follow the company’s fiscal Q1 2026 earnings, reported on April 14. During the quarter, the company reported $21.45 billion in revenue, reflecting 6.44% year-over-year growth but below the consensus of $345 million. On the bright side, the GAAP EPS of $1.60 topped expectations by $0.02.
Management noted growing diluted earnings per share by 15% year-over-year, reflecting improved profitability over the last year. Moreover, the revenue growth was attributed to a 5% increase in net interest income and an 8% increase in non-interest income.
The company has maintained 2026 net interest income guidance at roughly $50 billion and noninterest expense guidance at $55.7 billion. Separately, J.P. Morgan lowered the price target as part of the firm’s overall adjustment to the US large cap banks.
Wells Fargo & Company (NYSE:WFC) is a leading multinational financial services institution founded in 1852 and headquartered in San Francisco, California. The company provides banking, investment, mortgage, treasury, and consumer/commercial finance services, while serving large corporate and institutional clients in more than 35 countries.
2. CVS Health Corporation (NYSE:CVS)
Price: $80.69
Fwd P/E Ratio: 11.45
Number of Hedge Fund Holders: 88
CVS Health Corporation (NYSE:CVS) is one of the Best Undervalued Stocks to Buy Under $100. On May 5, the company announced that its pharmacy benefit arm is updating its commercial formularies effective July 1, 2026. This shift is aimed at lower-cost biosimilars over brand-name reference drugs.
Management noted that the most prominent change includes replacing Stelara with two FDA-approved interchangeable biosimilars called Pyzchiva and Yesintek. As per the new arrangement, most members are expected to pay nothing out-of-pocket. The release highlighted that the expansion extends beyond Stelara into specialty categories, including multiple sclerosis and rare blood disorders.
Moreover, the biosimilar alternatives to Tysabri and Soliris are also expected to gain preferred formulary status, thereby broadening affordable access across more conditions. CVS Health Corporation (NYSE:CVS) emphasized that all included biosimilars meet the same FDA standards for safety, effectiveness, and quality as their branded counterparts. These changes are based on three major priorities, including affordability, access, and long-term value for health plan sponsors and their members.
In separate news, recently, on May 8, Wells Fargo analyst Stephen Baxter raised the firm’s price target on the stock from $102 to $103, while maintaining an Overweight rating on the shares. The rating is based on the company’s Q1 2026 results, which topped estimates. CVS Health Corporation (NYSE:CVS) posted $100.43 billion in revenue, reflecting 6.17% year-over-year increase and surpassing expectations by $5.14 billion. Moreover, the GAAP EPS of $2.30 also topped expectations by $0.37.
CVS Health Corporation (NYSE:CVS) operates as a health solutions company.
1. EQT Corporation (NYSE:EQT)
Price: $58.56
Fwd P/E Ratio: 12.37
Number of Hedge Fund Holders: 92
EQT Corporation (NYSE:EQT) is one of the Best Undervalued Stocks to Buy Under $100. Recently, on May 5, Scott Gruber from Citi assigned a Buy rating on the stock and raised the price target from $66 to $70. Earlier, on April 26, Lloyd Byrne from Jefferies reiterated a Buy rating on EQT Corporation (NYSE:EQT) and also raised the price target from $76 to $77.
The ratings follow EQT’s FQ1 2026 earnings release on April 21. The company posted $3.38 billion in revenue, reflecting 94.20% year-over-year increase and ahead of expectations by $206.14 million. The GAAP EPS of $2.36 also topped the consensus by $0.29.
Jefferies noted that during the earnings call, management highlighted strong demand for gas driven by increased power generation. As a result, the firm finds the company to be placed attractively as a key supplier in times of incremental growth.
During the quarter, EQT delivered sales volumes ahead of management’s internal guidance. As a result, the free cash flow reached $1.8 billion, a record high, matching the total of full-year 2022 in just one quarter.
EQT Corporation (NYSE:EQT) is a premier and vertically integrated natural gas company. It has upstream and midstream operations focused on the Appalachian Basin.
While we acknowledge the potential of EQT to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than EQT and that has 100x upside potential, check out our report about the cheapest AI stock.
READ NEXT: 10 Best Stocks to Buy While the Market Is Down and 14 Stocks That Will Double in the Next 5 Years.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
